Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04556032 · ClinicalTrials.gov registry record · NA
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
A NA study, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04556032 is a NA study that was terminated before completion, run by Midwest Center for Metabolic and Cardiovascular Research. The registered enrollment target is 4 participants.
The verdict
NCT04556032, a NA study, was terminated before completion, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The objective of this study is to assess the effects of ergothioneine at two doses, compared to placebo, on cognition, mood, and sleep in healthy adult men and women.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT L-Ergothioneine 10 mg/d
- DIETARY_SUPPLEMENT L-Ergothioneine 25 mg/d
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2020-09-09 |
| Est. Completion | 2020-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04556032
The ClinicalTrials.gov registry entry for NCT04556032 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Midwest Center for Metabolic and Cardiovascular Research, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04556032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04556032 about?
NCT04556032 is a clinical study titled "Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women". The objective of this study is to assess the effects of ergothioneine at two doses, compared to placebo, on cognition, mood, and sleep in healthy adult men and women.
What is the current status of trial NCT04556032?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2020-09-09. Estimated completion is 2020-10-30.
What interventions are being tested in trial NCT04556032?
The interventions under investigation include: Placebo (OTHER), L-Ergothioneine 10 mg/d (DIETARY_SUPPLEMENT), L-Ergothioneine 25 mg/d (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04556032?
This trial is sponsored by Midwest Center for Metabolic and Cardiovascular Research, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.